nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancing LGBTQI health research
|
Poteat, Tonia C |
|
|
397 |
10289 |
p. 2031-2033 |
artikel |
2 |
Africa's need for more COVID-19 clinical trials
|
Makoni, Munyaradzi |
|
|
397 |
10289 |
p. 2037 |
artikel |
3 |
A global compact to counter vaccine nationalism
|
Jha, Prabhat |
|
|
397 |
10289 |
p. 2046-2047 |
artikel |
4 |
A history of US police violence
|
Bassett, Mary T |
|
|
397 |
10289 |
p. 2039-2040 |
artikel |
5 |
An acute-on-chronic health crisis in Gaza
|
Awadallah, Issam |
|
|
397 |
10289 |
p. 2043 |
artikel |
6 |
A new old treatment for lupus nephritis
|
Mok, Chi Chiu |
|
|
397 |
10289 |
p. 2027-2029 |
artikel |
7 |
Artificial intelligence, bias, and patients' perspectives
|
Obermeyer, Ziad |
|
|
397 |
10289 |
p. 2038 |
artikel |
8 |
Cambodia ends controversial COVID-19 restrictions
|
Tatum, Megan |
|
|
397 |
10289 |
p. 2035 |
artikel |
9 |
Chronic pain: an update on burden, best practices, and new advances
|
Cohen, Steven P |
|
|
397 |
10289 |
p. 2082-2097 |
artikel |
10 |
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
|
|
|
|
397 |
10289 |
p. 2049-2059 |
artikel |
11 |
Convalescent plasma in patients hospitalised with COVID-19
|
Liu, Sean T H |
|
|
397 |
10289 |
p. 2024-2025 |
artikel |
12 |
Cultures of contagion
|
Prasad, Aarathi |
|
|
397 |
10289 |
p. 2041 |
artikel |
13 |
Department of Error
|
|
|
|
397 |
10289 |
p. 2048 |
artikel |
14 |
Department of Error
|
|
|
|
397 |
10289 |
p. 2048 |
artikel |
15 |
Department of Error
|
|
|
|
397 |
10289 |
p. 2048 |
artikel |
16 |
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
|
Rovin, Brad H |
|
|
397 |
10289 |
p. 2070-2080 |
artikel |
17 |
Health must be a top priority in the Iran nuclear deal
|
Sajadi, Haniye Sadat |
|
|
397 |
10289 |
p. 2047-2048 |
artikel |
18 |
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
|
Shaw, Robert H |
|
|
397 |
10289 |
p. 2043-2046 |
artikel |
19 |
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
|
Ridker, Paul M |
|
|
397 |
10289 |
p. 2060-2069 |
artikel |
20 |
Immunotactoid glomerulopathy associated with monoclonal gammopathy
|
Inotani, Satoshi |
|
|
397 |
10289 |
p. 2081 |
artikel |
21 |
Inappropriate use of global health metrics for analysis of the determinants of health
|
Canning, David |
|
|
397 |
10289 |
p. 2048 |
artikel |
22 |
John Irwin Harper
|
Watts, Geoff |
|
|
397 |
10289 |
p. 2042 |
artikel |
23 |
Neuromodulation for chronic pain
|
Knotkova, Helena |
|
|
397 |
10289 |
p. 2111-2124 |
artikel |
24 |
Nociplastic pain: towards an understanding of prevalent pain conditions
|
Fitzcharles, Mary-Ann |
|
|
397 |
10289 |
p. 2098-2110 |
artikel |
25 |
Pragmatic but flawed: the NICE guideline on chronic pain
|
Eccleston, Christopher |
|
|
397 |
10289 |
p. 2029-2031 |
artikel |
26 |
Rethinking chronic pain
|
The Lancet, |
|
|
397 |
10289 |
p. 2023 |
artikel |
27 |
800 000 South Sudanese to lose access to health care
|
Devi, Sharmila |
|
|
397 |
10289 |
p. 2034 |
artikel |
28 |
Targeting IL-6 in patients at high cardiovascular risk
|
Christoffersen, Mette |
|
|
397 |
10289 |
p. 2025-2027 |
artikel |
29 |
Yemen's health system has “collapsed”, warns UN
|
Devi, Sharmila |
|
|
397 |
10289 |
p. 2036 |
artikel |